Jan 22, 2018 Cellectar Biosciences to Participate at Noble Capital Markets’ Fourteenth Annual Investor Conference Learn More
Dec 6, 2017 Cellectar Announces Expansion of Relapsed/Refractory Multiple Myeloma Cohort in Phase 2 Trial of CLR 131 Learn More